E. Zhang-Velten

Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical Trial.

Joe Y. Chang, P. Iyengar, K. Westover, 2021, JAMA oncology.

The Evolving Role of Hypofractionated Radiotherapy in Older Adults with Gastrointestinal Cancers.

N. Sanford, E. Zhang-Velten, 2022, Seminars in radiation oncology.

Thirteen-Year Survival in a Patient With Diffuse Bilateral Lepidic-Predominant Adenocarcinoma: A Case Report of Lung Transplantation and Local Salvage

K. Westover, D. Gerber, E. Zhang-Velten, 2020, JTO clinical and research reports.

Hypofractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer-Does Size Matter?-Reply.

P. Iyengar, R. Timmerman, E. Zhang-Velten, 2022, JAMA oncology.

Patterns of Dose Escalation Among Patients With Esophageal Cancer Undergoing Definitive Radiation Therapy: 2006-2016

M. Folkert, T. Aguilera, N. Sanford, 2020, Advances in radiation oncology.

Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy

R. Hannan, J. Brugarolas, A. Christie, 2018, Oncoimmunology.

Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes.

Steve B. Jiang, R. Timmerman, X. Gu, 2021, Transplantation and cellular therapy.

A How-To Compendium for GammaPod Treatments, Clinical Workflow, and Clinical Program at an Early Adopting Institution.

H. Choy, R. Timmerman, You Zhang, 2022, Practical radiation oncology.